CLIFFORD SWAN INVESTMENT COUNSEL LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 161 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
CLIFFORD SWAN INVESTMENT COUNSEL LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$1,358,000
+152.4%
21,408
+12.0%
0.07%
+135.7%
Q3 2019$538,000
+6.3%
19,1080.0%0.03%
+3.7%
Q2 2019$506,000
-5.9%
19,108
-34.8%
0.03%
-6.9%
Q1 2019$538,000
+4.7%
29,308
-29.2%
0.03%
-6.5%
Q4 2018$514,000
-21.5%
41,408
+21.2%
0.03%
-8.8%
Q3 2018$655,00034,1780.03%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders